The global bronchoscopes market size was valued at USD 3.46 billion in 2025 and is projected to grow from USD 3.80 billion in 2026 to USD 8.03 billion by 2034, registering a CAGR of 9.8% during the forecast period from 2026 to 2034. North America dominated the bronchoscopes market with a market share of 38.4% in 2025.
Bronchoscopes are flexible or rigid medical instruments used to view the inside of the airways and lungs. They help doctors diagnose and treat respiratory conditions by inserting a thin tube through the nose or mouth to examine bronchial passages, collect samples, and perform minimally invasive procedures safely and effectively.
The bronchoscopes market demand is driven by increasing respiratory diseases, lung cancer prevalence, and growing need for minimally invasive diagnostic procedures. Advancements in imaging technology, a rising geriatric population, and higher ICU admissions are driving adoption. Hospitals and clinics are increasingly investing in bronchoscopy systems for accurate airway examination and treatment procedures.
Download a Free Sample To learn more about this report,
Next-Generation EBUS Designs Simplifying Pulmonary Diagnosis
Complex lung and lymph-node assessment is placing more focus on bronchoscope designs that combine ultrasound guidance with clearer access to target areas. This transition is bringing slimmer distal sections, improved ultrasound interfaces, and simplified tip designs into EBUS procedures; Fujifilm launched the EB-710US in 2026 with a balloon-less design intended to improve visibility during peripheral lung examination. The outcome is a more streamlined diagnostic workflow, easier tissue targeting, and stronger integration between imaging and biopsy procedures.
Specimen Collection Becoming Integrated with Bronchoscopy Platforms
Bronchoalveolar lavage and bronchial-wash procedures require controlled specimen handling to protect sample quality and reduce exposure during transfer. This transition is integrating closed collection accessories directly with bronchoscopy systems; Verathon introduced SamplePro in 2026 for its BFlex 2 platform as a self-sealing solution for BAL and bronchial-wash collection. The outcome is a more organized bronchoscopy workflow with simpler specimen handling, lower spill risk, and more consistent sample transfer.
Higher Burden of Lung Cancer and Chronic Respiratory Diseases and Increasing Need for Bedside Airway Visualization in Critical Care Drive Market
Higher incidence of lung cancer, COPD, pneumonia, and other respiratory conditions increases demand for bronchoscopic diagnosis and airway assessment. Hospitals use bronchoscopy to examine suspicious lesions, investigate persistent respiratory symptoms, and support treatment planning for pulmonary diseases. Lung cancer patients, for example, commonly undergo bronchoscopy for airway examination and tissue sampling during diagnosis. This expanding patient pool raises bronchoscopy procedure volumes and strengthens demand for bronchoscopes across pulmonary and oncology departments.
Higher numbers of critically ill and mechanically ventilated patients increase demand for bronchoscopes that can provide airway visualization directly at the bedside. Intensive care teams use portable and single-use bronchoscopes for secretion management, difficult airway assessment, and confirmation of airway conditions without transferring unstable patients. ICU applications therefore create recurring equipment requirements across emergency and critical-care settings. This demand-side transition expands bronchoscopes use beyond dedicated endoscopy suites and supports higher procurement by hospitals.
Reprocessing and Infection-Control Burden and Limited Access in Smaller and Rural Healthcare Facilities Restrain Market Expansion
Reusable bronchoscopes require thorough cleaning, disinfection, drying, storage, and monitoring after every procedure. These steps increase labor needs, turnaround time, and operating costs while placing greater pressure on hospital infection-control systems. Higher reprocessing complexity can reduce procedural efficiency and limit broader bronchoscope adoption.
Smaller and rural hospitals often lack dedicated bronchoscopy units, trained specialists, advanced imaging support, and sufficient procedure volumes. Limited infrastructure makes investment in bronchoscopy systems less economical and reduces the ability to offer these procedures locally. This restricts geographic penetration and slows growth of the Bronchoscopes Market.
Growth of Bronchoscope Reprocessing, Maintenance, and Lifecycle Service Programs and Wider Adoption of Bronchoscopy Systems in Ambulatory Surgical Centers and Specialty Clinics Offers Growth Opportunities
Bronchoscope manufacturers, service providers, and hospital equipment partners can use this opportunity to build recurring revenue beyond initial device sales. Reprocessing support, preventive maintenance, repair contracts, software updates, and lifecycle management packages can deepen long-term customer relationships. Companies such as Olympus and KARL STORZ are well positioned through their established endoscopy service and maintenance networks.
Outpatient care settings such as ambulatory surgical centers and specialty clinics offer a new avenue for expanding bronchoscopy services. Compact systems, flexible financing options, and procedure-specific configurations can create revenue through equipment sales, leasing, bundled packages, and recurring service contracts. Companies such as Ambu, Olympus, and Boston Scientific are well positioned to capture this opportunity through their established bronchoscopy portfolios.
Device Reliability and Unplanned Procedure Disruptions and Shortage of Specialized Bronchoscopy Skills
Bronchoscope manufacturers must maintain reliable performance across complex visualization, navigation, and accessory systems, as equipment failure can interrupt procedures and weaken hospital confidence in newer platforms. Product corrections also create servicing, replacement, and customer-support burdens that can slow commercial expansion. In 2024, Noah Medical recalled certain Galaxy System units after defective power-supply components were found capable of causing unexpected system failure and aborted procedures.
Advanced bronchoscopy increasingly requires physicians and clinical teams trained in EBUS, navigation, biopsy techniques, and therapeutic procedures. Uneven availability of such expertise can limit procedure volumes and make hospitals cautious about adopting sophisticated bronchoscopy platforms. Manufacturers consequently face longer customer-training cycles and greater investment in clinical education before they can scale installations across healthcare systems.
The flexible segment dominated the bronchoscopes market with a market share of 81.3% in 2025 and is also expected to register the fastest CAGR of 9.16% during the forecast period. Its broad use in diagnostic and therapeutic bronchoscopy is supported by improved maneuverability through complex airway structures, compatibility with biopsy and imaging tools, and suitability for both routine and advanced pulmonary procedures.
The rigid segment remains important for selected interventional procedures that require a wider working channel, airway stabilization, foreign-body removal, or management of major airway obstruction.
Request Customizationto receive a tailored report.
The reusable segment dominated the bronchoscopes market with a market share of 63.1% in 2025, supported by repeated use across high-volume bronchoscopy departments and the availability of established reprocessing infrastructure in large healthcare facilities. Its durability and compatibility with a wide range of diagnostic and therapeutic accessories continue to support adoption in routine clinical workflows.
The disposable segment is expected to grow at the fastest CAGR of 11.24% during the forecast period, driven by infection-prevention priorities, reduced reprocessing requirements, and the convenience of immediate availability in intensive care, emergency, and isolation settings.
The oncology segment dominated the bronchoscopes market with a market share of 31.6% in 2025, supported by the central role of bronchoscopy in detecting suspicious airway lesions, obtaining tissue samples, staging lung cancer, and guiding further treatment decisions. The expanding use of endobronchial ultrasound and advanced biopsy techniques further strengthens bronchoscopy in pulmonary oncology.
The ICU airway management segment is expected to grow at the fastest CAGR of 9.42% during the forecast period, driven by the need for bedside airway inspection, secretion clearance, tube-position assessment, and support during difficult ventilation cases. The pneumonia & infectious diagnosis segment benefits from specimen collection for respiratory infections, while the others segment includes additional diagnostic and therapeutic pulmonary procedures.
The hospitals segment dominated the bronchoscopes market with a market share of 68.5% in 2025, supported by the concentration of pulmonology departments, intensive care units, operating rooms, and advanced diagnostic facilities within hospital settings. Access to trained specialists and multidisciplinary care also enables hospitals to manage complex bronchoscopy procedures.
The ambulatory surgical centers segment is expected to grow at the fastest CAGR of 9.67% during the forecast period, supported by the shift of selected bronchoscopy procedures toward outpatient settings with shorter patient stays and streamlined workflows. The specialty clinics segment remains relevant for focused respiratory evaluation, follow-up bronchoscopy, and procedure-based pulmonary care.
Speak to an Analystto discuss market opportunities.
The North America bronchoscopes market accounted for the largest regional share of 38.4% in 2025, supported by established pulmonary-care infrastructure, advanced diagnostic capabilities, and widespread use of bronchoscopy in lung cancer and critical-care procedures. The U.S. bronchoscopes market benefits from continued expansion of lung-cancer screening and diagnostic pathways, which increases the number of patients requiring tissue sampling and follow-up bronchoscopic evaluation after suspicious imaging findings.
The Canada bronchoscopes market is supported by the clinical use of bronchoscopy for investigating suspected lung tumors and obtaining biopsy samples, alongside continued efforts to improve cancer detection and respiratory care. Public Health Agency of Canada guidance specifically identifies bronchoscopy among diagnostic procedures used when lung cancer is suspected.
Unlock Regional Insightsto access country-level data, & regional trends.
The Asia-Pacific bronchoscopes market is expected to register the fastest CAGR of 10.46% during the forecast period, supported by expansion of respiratory diagnostics, lung-cancer screening, and hospital pulmonary-care capacity. The Japan bronchoscopes market benefits from its advanced endoscopy ecosystem and large elderly population, which supports procedural volumes for pulmonary diagnosis and airway management.
The China bronchoscopes market is supported by the national 2024–2030 chronic respiratory disease program, which promotes earlier detection of COPD and wider respiratory diagnostic capacity, while national lung-cancer guidance recommends annual LDCT screening for high-risk adults aged 50–74, creating additional downstream need for bronchoscopic confirmation of suspicious lesions. The South Korea bronchoscopes market benefits from strong tertiary-hospital capabilities and adoption of advanced interventional pulmonology, while the India market is supported by expansion of respiratory specialty care and bronchoscopy access across large hospital networks.
The Europe bronchoscopes market is expected to grow at a CAGR of 7.94% during the forecast period, supported by structured cancer-screening programs, interventional pulmonology, and modernization of respiratory diagnostic services. The U.K. bronchoscopes market is supported by England’s plan to complete national lung-cancer screening rollout by 2030, with more than 6 million people expected to receive invitations between now and 2035, increasing follow-up diagnostic activity for detected abnormalities.
The Germany bronchoscopes market is supported by its established hospital and specialist respiratory-care network, where bronchoscopy remains important for biopsy, airway examination, and interventional procedures. The France bronchoscopes market is supported by continued expansion of early cancer diagnosis and minimally invasive pulmonary procedures, creating opportunities for advanced video bronchoscopes, EBUS systems, and single-use devices.
The bronchoscopes market is fragmented, with multinational medical-device companies, specialized endoscopy manufacturers, and single-use bronchoscope suppliers competing across diagnostic and therapeutic applications. Leading players include Olympus Corporation, FUJIFILM Holdings Corporation, Ambu A/S, KARL STORZ SE & Co. KG, and Boston Scientific Corporation, which together account for approximately 10–15% of the global market share.
Established players compete through imaging performance, broad bronchoscopy portfolios, clinical support, and established hospital relationships. Emerging and regional players within the Bronchoscopes Market ecosystem compete through cost-effective devices, single-use product development, application-specific designs, and flexible distribution strategies, helping them gain access to hospitals and specialty clinics.
Customize This Report to Match Your Strategic Objectives
Author's Details
Healthcare Lead
Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, competitive dynamics, and market opportunities. Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.
Artificial Lung Market Size, Share, Growth, Analysis, 2034
Aesthetic Threads Market Size, Share, Growth, Forecast, 2034
Middle East And Africa Diabetes Devices Market Size and Forecast 2034
Bladder Scanners Market Size, Share, Growth, Forecast, 2034
Japan Dialyzer Market Size, Top Share, Demand And Forecast to 2034
Europe Electrocardiograph (ECG) Market Size, Growth & Demand Forecast to 2034
We are featured on:
sales@straitsresearch.com